CSE Bulletin: Delist - Emerald Health Therapeutics, Inc. (EMH)

Toronto, Ontario--(Newsfile Corp. - Le 11 novembre/November 2022) - Emerald Health Therapeutics, Inc. ("Emerald" or the "Company") announced today that its Plan of Arrangement with Skye Bioscience, Inc. ("Skye") has closed and that it has entered into agreements to divest its remaining cannabis assets and licenses, including its Quebec cannabis production facility.

Emerald shares will be exchanged for 1.95 shares of Skye. Registered shareholders holding an Emerald share certificate may submit a completed letter of transmittal along with their share certificate to Computershare Investor Services Inc., to initiate their share exchange.

The common shares of Emerald Health Therapeutics will be delisted from the CSE at market close on November 11, 2022.

For more information, see the Emerald Health Therapeutics news release.

_________________________________

Emerald Health Therapeutics, Inc. (« Emerald » ou la « Société ») a annoncé aujourd'hui que son plan d'arrangement avec Skye Bioscience, Inc. (« Skye ») a été conclu et qu'elle a conclu des accords pour céder ses actifs de cannabis restants et licences, y compris son installation de production de cannabis au Québec.

Les actions Emerald seront échangées contre 1,95 action Skye. Les actionnaires inscrits titulaires d'un certificat d'actions Emerald peuvent soumettre une lettre d'envoi dûment remplie avec leur certificat d'actions à Computershare Investor Services Inc., afin d'initier leur échange d'actions.

Les actions ordinaires de Emerald Health Therapeutics seront radiées du CSE à la clôture du marché le 11 novembre 2022.

Pour plus d'informations, consultez le communiqué de presse de Emerald Health Therapeutics.

Date:	Market Close/Clôture du marchés le 11 NOV 2022
Symbol(s)/Symbole(s):	EMH

If you have any questions or require further information, please contact Listings at (416) 367-7340 or E-mail: [email protected].

Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse: [email protected].

Comment On!

Comment

Image

140

Upload limit is up to 1mb only

Disclaimer :: Use of this site is subject to, and your continued use constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information. INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion; however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment. Users should always consult with and obtain advice from their professional licensed financial advisor, including their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment or trading securities do so with caution. Users should perform full due diligence and investigate any security fully before making an investment or before the execution of a security trade based upon information learned through INK. Investors should obtain annual reports and other company information to complete their own due diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this website. On this site, there may be third party content, content from authors or links to third-party sites or pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI® is a registered trade-mark owned by the Alberta Securities Commission.Read less

Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.

Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.